Evita Weagel

Evita Weagel, Ph.D. is the Co-Founder & CEO of Eris Biotech with a background in Microbiology and Molecular Biology. Evita has held various positions in research and academia, including roles at Sumitomo Pharma Oncology, Brigham Young University, and Tolero Pharmaceuticals, Inc. Evita has also been involved in summer research fellowships and has pursued additional education in Data Science and Business Analytics.